Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry A Couture

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Nature Biotechnology|June 10, 2010
Scalable pluripotent stem cell cultureLarry A Couture
Stem Cell Research & Therapy|May 16, 2013
Pluripotent stem cells for Parkinson's disease: progress and challengesXianmin Zeng, Larry A Couture
Stem Cells Translational Medicine|August 20, 2015
2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell DevelopmentLarry A Couture, Melissa K Carpenter
Regenerative Medicine|July 17, 2010
Regulatory considerations for the development of autologous induced pluripotent stem cell therapiesMelissa K Carpenter, Larry A Couture
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2014
The suspension culture of undifferentiated human pluripotent stem cells using spinner flasksVincent C Chen, Larry A Couture
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2011
GMP scale-up and banking of pluripotent stem cells for cellular therapy applicationsLara J Ausubel, Patricia M Lopez, Larry A Couture
The Journal of Clinical Investigation|July 2, 2015
Hurdles to clinical translation of human induced pluripotent stem cellsEvgenios Neofytou, Connor Galen O'Brien, Larry A Couture, et al.
Cytotherapy|May 14, 2013
Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantationQiuyue Liu, Oliver Z Pedersen, Jun Peng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 24, 2010
Replication-competent lentivirus analysis of clinical grade vector productsKenneth Cornetta, Jing Yao, Aparna Jasti, et al.
Vaccine|August 24, 2005
Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP)Laura E Johnson, Thomas P Frye, Alana R Arnot, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Nature Biotechnology|June 10, 2010
Scalable pluripotent stem cell cultureLarry A Couture
Stem Cell Research & Therapy|May 16, 2013
Pluripotent stem cells for Parkinson's disease: progress and challengesXianmin Zeng, Larry A Couture
Stem Cells Translational Medicine|August 20, 2015
2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell DevelopmentLarry A Couture, Melissa K Carpenter
Regenerative Medicine|July 17, 2010
Regulatory considerations for the development of autologous induced pluripotent stem cell therapiesMelissa K Carpenter, Larry A Couture
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2014
The suspension culture of undifferentiated human pluripotent stem cells using spinner flasksVincent C Chen, Larry A Couture
Methods in Molecular Biology (Clifton, N.J.)|August 9, 2011
GMP scale-up and banking of pluripotent stem cells for cellular therapy applicationsLara J Ausubel, Patricia M Lopez, Larry A Couture
The Journal of Clinical Investigation|July 2, 2015
Hurdles to clinical translation of human induced pluripotent stem cellsEvgenios Neofytou, Connor Galen O'Brien, Larry A Couture, et al.
Cytotherapy|May 14, 2013
Optimizing dopaminergic differentiation of pluripotent stem cells for the manufacture of dopaminergic neurons for transplantationQiuyue Liu, Oliver Z Pedersen, Jun Peng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 24, 2010
Replication-competent lentivirus analysis of clinical grade vector productsKenneth Cornetta, Jing Yao, Aparna Jasti, et al.
Vaccine|August 24, 2005
Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP)Laura E Johnson, Thomas P Frye, Alana R Arnot, et al.
Pageof 3